分组1 - Equillium, Inc. reported quarterly earnings of $0.01 per share, exceeding the Zacks Consensus Estimate of a loss of $0.15 per share, representing an earnings surprise of 106.67% [1] - The company posted revenues of $13.85 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 69.98%, compared to revenues of $9.12 million a year ago [2] - Equillium has surpassed consensus EPS estimates and revenue estimates for the last four quarters [2] 分组2 - The stock has added about 1.5% since the beginning of the year, underperforming the S&P 500's gain of 9% [3] - The current consensus EPS estimate for the coming quarter is $0.43 on revenues of $36.35 million, while for the current fiscal year, it is -$0.12 on revenues of $41.09 million [7] - The Medical - Biomedical and Genetics industry is currently in the top 37% of Zacks industries, indicating a favorable outlook for stocks in this sector [8]
Equillium, Inc. (EQ) Beats Q2 Earnings and Revenue Estimates